Bio Preventive Medicine Corp.'s DNlite-IVD103 granted TFDA approval

撰文GlobalBio & Investment
日期2024-01-25
EnglishFrenchGermanItalianPortugueseRussianSpanish
Bio Preventive Medicine Corp.'s DNlite-IVD103 granted TFDA approval
"Better safe than sorry."
Congratulations to Bio Preventive Medicine Corp. for their innovative kidney disease test kit, DNlite-IVD103, granted TFDA approval!
This breakthrough benefits diabetic patients by predicting disease progression two years in advance, potentially saving billions in healthcare costs. It's a pioneering step in Taiwan's IVD sector, marking the first international foray into chronic disease healthcare. Read more: https://news.gbimonthly.com/tw/article/show.php?num=64123
 
Follow #Globalbio for more updates! 
#BioPreventiveMedicine #MedicalInnovation #DiabetesAwareness #TFDAApproval #IVD #HealthTec